Table 1 Clinicopathological features of the patients with locally advanced NSCLC

Age

60 ± 9.31

 > 60

14 (50.00)

  ≤ 60

14 (50.00)

Gender

 Male

24 (85.71)

 Female

4 (14.29)

Stage

 IIIA

13 (46.43)

 IIIB

15 (53.57)

Pathological type

 Adenocarcinoma

11 (39.29)

 Squamous cell carcinoma

17 (60.71)

Short-term outcome (RECIST)

 Complete response

1 (3.57)

 Partial response

14 (50.00)

 Stable disease

8 (28.57)

 Progressive disease

5 (17.86)

PFS

17 (range 7.89 ~ 26.12) months

OS

36 (range 11.24 ~ 60.76) months

 1 year survival rate

25 (89.29)

 3 years survival rate

15 (53.57)

 5 years survival rate

6 (21.43)